The biggest vaccination campaign of all time is making great progress around the world. As more vaccines continue to be developed, the numbers of people being inoculated are soaring. As of February 9, it’s estimated more than 130 million doses have been used in more than 70 countries worldwide. Israel’s inoculation efforts had been drawing attention - as well as progress in the United Arab Emirates and the UK - but now it’s the vaccine speed of Serbia which is turning heads. Yet despite the progress, a host of important questions surrounding the vaccines remain unanswered.

In this #AskTheAgenda special, Stephen Cole chooses some of the most prominent queries and concerns from viewers - such as whether the vaccines work on new variants, and how long immunity lasts - and gets the answers from Jerome Kim, Director General of the International Vaccine Institute.

The question of who should be prioritised for a COVID-19 vaccine is one many countries are still struggling to answer with complete confidence. Should the world be taking one single uniformed approach, or does it depend on a country’s population size and demographic?

To discuss further Stephen Cole is joined by Jane Williams, Doctor of Public Health Ethics at the University of Sydney’s Center for Values, Ethics and the Law who explains the various strategies and tough decisions countries face - especially if there is a vaccine shortage.

Find out more on #TheAgenda​​: https://newseu.cgtn.com/news/2021-02-14/Your-vaccine-questions-answered-AskTheAgenda-with-Stephen-Cole--XPf7JA4Ek8/index.html

🔴 Subscribe to the CGTN Europe YouTube channel for all the latest on Business, Technology, Environment and Current Affairs

📲 Follow CGTN Europe on social media and other platforms👇🏼
https://stories.cgtneurope.tv/follow-cgtn-europe/index.html